APA (7th ed.) Citation

B, A., R, C., A, R., T, B., M, M., L, S., . . . R, S. (2016). Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients. Drug design, development and therapy, 10, 2041. https://doi.org/10.2147/DDDT.S106153

Chicago Style (17th ed.) Citation

B, Amato, et al. "Fondaparinux Vs Warfarin for the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients." Drug Design, Development and Therapy 10 (2016): 2041. https://doi.org/10.2147/DDDT.S106153.

MLA (9th ed.) Citation

B, Amato, et al. "Fondaparinux Vs Warfarin for the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients." Drug Design, Development and Therapy, vol. 10, 2016, p. 2041, https://doi.org/10.2147/DDDT.S106153.